Validation of Prognostic Factors in Malignant Pleural Mesothelioma: A Retrospective Analysis of Data from Patients Seeking Compensation from the New South Wales Dust Diseases Board
Authors:
- Janette VardyJVJanette Vardy
- Mark ChatfieldMCMark Chatfield
- Peter CortePCPeter Corte
- Nick PavlakisNPNick Pavlakis
- Christopher ClarkeCCChristopher Clarke
- Nico van ZandwijkNZNico van Zandwijk
- Stephen ClarkeSCStephen Clarke
- 1 January 2013
- journal article
- research article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 14 (1) , 70-77
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic TherapyClinical Cancer Research, 2010
- A Clinical, Radiographic and Laboratory Evaluation of Prognostic Factors in 363 Patients with Malignant Pleural MesotheliomaRespiration, 2010
- Surgical assessment of malignant pleural mesothelioma: have we reached a critical stage?European Journal of Cardio-Thoracic Surgery, 2010
- Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung CancerClinical Cancer Research, 2008
- Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancerInternational Journal of Colorectal Disease, 2007
- Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responsesEuropean Respiratory Journal, 2006
- Malignant mesothelioma: Prognostic factors in a prospective study of 98 patientsLung Cancer, 1992
- Malignant mesothelioma of the pleuraJournal of Molecular Medicine, 1988
- Survival patterns for malignant mesothelioma: The seer experienceInternational Journal of Cancer, 1988